XenoPort (XNPT) Reports In-Line Q3 EPS

XenoPort (NASDAQ: XNPT) reported Q3 EPS of ($0.38), in-line with the analyst estimate of ($0.38). Revenue for the quarter came in at $11.4 million versus the consensus estimate of $11.77 million.

Vincent J. Angotti, chief executive officer of XenoPort, stated, “We continue to see strong sales performance, which gives us confidence that our strategy for HORIZANT revenue growth is succeeding thus far. Our sales in the quarter were primarily achieved by approximately 70 NeuroHealth Specialists that have been in the field since at least October 2014. Our 50 new Specialists, who joined our team in July, are highly motivated and showing early signs of productivity. We believe that the 120 territories we now cover, when fully productive, will allow us to address approximately 25% of the total market opportunity for the currently-approved indications for HORIZANT.”

For earnings history and earnings-related data on XenoPort (XNPT) click here.

You May Also Be Interested In

• Wex, Inc. (WEX) Tops Q2 EPS by 29c; raises guidance
• NB Bancorp, Inc. (NBBK) Tops Q2 EPS by 14c
• First Bancorp (FNLC) Tops Q2 EPS by 85c